New device aims to seal dangerous brain aneurysms
NCT ID NCT07205302
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called a flow diverter to treat brain aneurysms that are not balloon-shaped. The goal is to block blood flow into the aneurysm, helping it heal and preventing rupture. About 168 adults aged 18 to 80 will be enrolled, and the main outcome is complete blockage of the aneurysm one year after the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 168 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with intracranial Non-saccular aneurysm
- Ages
-
18 to 80 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 18 to 80 years, any gender 2. Diagnosed as a non-saccular aneurysm in the patient's intracranial region 3. Subject or guardian is able to understand the purpose of study, shows sufficient compliance with the study protocol and provides a signed informed consent form Exclusion Criteria: 1. Aneurysm rupture within 30 days before enrollment; 2. Diagnosis of multiple aneurysms and requiring reoperation within 12 months 3. Conditions that are not appropriate for stent delivery and deployment judged by investigators (severe stenosis of parent artery, severe tortuosity of parent artery, stent failing to reach the lesion, stent in the target lesion of parent artery, etc.); 4. Heart, lung, liver and renal failure or other severe diseases (intracranial tumor, systemic infection, disseminated intravascular coagulation, myocardial infarction within 12 months before enrollment, history of severe psychosis, severe stenosis or occlusion of cerebral feeding artery, etc.); 5. Major surgery within 30 days before enrollment，or planned to undergo surgery within 360 days after enrollment; 6. Known allergies or contraindications to anesthetics, anticoagulants, and antiplatelet drugs; 7. Known allergy to nickel-titanium alloy metal materials; 8. Life expectancy \<12 months; 9. Pregnant or breastfeeding women; 10. Subject has participated in other clinical trials within 1 month before signing informed consent; 11. Other conditions judged by the investigators as unsuitable for enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intracranial non-saccular aneurysms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.